Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3I28

Crystal Structure of soluble epoxide Hydrolase

3I28 の概要
エントリーDOI10.2210/pdb3i28/pdb
関連するPDBエントリー3I1Y
分子名称Epoxide hydrolase 2, 4-cyano-N-{(3S)-3-(4-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]propyl}benzamide (3 entities in total)
機能のキーワードhydrolase, aromatic hydrocarbons catabolism, detoxification, magnesium, metal-binding, peroxisome
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: P34913
タンパク質・核酸の鎖数1
化学式量合計63122.12
構造登録者
Farrow, N.A. (登録日: 2009-06-29, 公開日: 2009-10-13, 最終更新日: 2024-02-21)
主引用文献Eldrup, A.B.,Soleymanzadeh, F.,Taylor, S.J.,Muegge, I.,Farrow, N.A.,Joseph, D.,McKellop, K.,Man, C.C.,Kukulka, A.,De Lombaert, S.
Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
J.Med.Chem., 52:5880-5895, 2009
Cited by
PubMed Abstract: Inhibition of soluble epoxide hydrolase (sEH) is hypothesized to lead to an increase in circulating levels of epoxyeicosatrienoic acids, resulting in the potentiation of their in vivo pharmacological properties. As part of an effort to identify inhibitors of sEH with high and sustained plasma exposure, we recently performed a high throughput screen of our compound collection. The screen identified N-(3,3-diphenyl-propyl)-nicotinamide as a potent inhibitor of sEH. Further profiling of this lead revealed short metabolic half-lives in microsomes and rapid clearance in the rat. Consistent with these observations, the determination of the in vitro metabolic profile of N-(3,3-diphenyl-propyl)-nicotinamide in rat liver microsomes revealed extensive oxidative metabolism and a propensity for metabolite switching. Lead optimization, guided by the analysis of the solid-state costructure of N-(3,3-diphenyl-propyl)-nicotinamide bound to human sEH, led to the identification of a class of potent and selective inhibitors. An inhibitor from this class displayed an attractive in vitro metabolic profile and high and sustained plasma exposure in the rat after oral administration.
PubMed: 19746975
DOI: 10.1021/jm9005302
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.95 Å)
構造検証レポート
Validation report summary of 3i28
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon